Changsha Xjun Technology
Ordered peptides from Changsha Xjun Technology? Mail in a sample (US only) and let us test it.
Test my supplyChangsha Xjun Technology's purity-focus record is current but narrow, with all rated evidence coming from Retatrutide. Retatrutide generally held identity and mostly cleared purity, but one 10 mg vial fell to 98.51% with +24% fill; the follow-up recovered, while missing batch IDs keep traceability thin.
eChem captures and chjunxi.com WHOIS show a platform-led operation with no independent public site and unresolved registry identity. The report traces BDO exposure, sales personas, COA-verification gaps, and a Caoquan network lead that does not resolve cleanly.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Changsha Xjun Technology rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
10 Jul 2026 | Pass | Tirzepatide Changsha Xjun Technology | lab name | View COA | |||
3 Mar 2026 | Pass | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
22 Feb 2026 | Fail | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
22 Feb 2026 | Pass | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
22 Feb 2026 | Pass | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
22 Feb 2026 | Pass | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
31 Aug 2025 | Pass | Retatrutide Changsha Xjun Technology | lab name | View COA | |||
About Changsha Xjun Technology test results from Finnrick
Changsha Xjun Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Changsha Xjun Technology peptides in this dataset are Retatrutide (6 tests), Tirzepatide (1 test) and Tesamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.
Ordered peptides from Changsha Xjun Technology? Mail in a sample (US only) and let us test it.
Test my supply